Winning Health Technology Group Co., Ltd. (SHE:300253)
8.52
-0.09 (-1.05%)
Apr 17, 2026, 3:08 PM CST
SHE:300253 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,762 | 1,336 | 1,114 | 1,282 | 1,601 |
Trading Asset Securities | - | 3 | - | - | - |
Cash & Short-Term Investments | 1,762 | 1,339 | 1,114 | 1,282 | 1,601 |
Cash Growth | 31.60% | 20.18% | -13.07% | -19.92% | 56.06% |
Accounts Receivable | 2,872 | 3,379 | 3,342 | 2,693 | 2,215 |
Other Receivables | 99.43 | 131.88 | 158.13 | 135.25 | 151.35 |
Receivables | 2,972 | 3,511 | 3,500 | 2,829 | 2,366 |
Inventory | 100.3 | 111.11 | 110.74 | 97.5 | 133.09 |
Prepaid Expenses | 2.42 | 1.12 | 2.12 | 1.02 | 1.18 |
Other Current Assets | 88.55 | 132.85 | 126.7 | 102.73 | 74.16 |
Total Current Assets | 4,925 | 5,095 | 4,854 | 4,312 | 4,175 |
Property, Plant & Equipment | 479.18 | 492.9 | 508.88 | 528.86 | 540.99 |
Long-Term Investments | 870.87 | 898.69 | 946.76 | 960.56 | 993.46 |
Goodwill | 409.9 | 497.59 | 589.62 | 596.23 | 637.95 |
Other Intangible Assets | 1,447 | 1,106 | 1,037 | 505.43 | 940.32 |
Long-Term Accounts Receivable | 12.87 | 17.56 | 21.82 | 29.57 | 18.38 |
Long-Term Deferred Tax Assets | 268.44 | 193.18 | 214.34 | 205.47 | 177.19 |
Long-Term Deferred Charges | 109.96 | 455.74 | 377.01 | 684.03 | 13.12 |
Total Assets | 8,523 | 8,756 | 8,549 | 7,822 | 7,496 |
Accounts Payable | 672.67 | 697.53 | 674.69 | 602.97 | 499.25 |
Accrued Expenses | 363.98 | 425.47 | 480.9 | 400.78 | 286.33 |
Short-Term Debt | 15.06 | 40.29 | 58.03 | 42.86 | - |
Current Portion of Long-Term Debt | 13.88 | 11.57 | 7.73 | 3.87 | 2.26 |
Current Portion of Leases | 8.33 | 13.56 | 12.87 | 15.05 | 13.83 |
Current Income Taxes Payable | 7.9 | 16.4 | 65.12 | 57.21 | 55.03 |
Current Unearned Revenue | 270.65 | 141.3 | 144.68 | 194.26 | 202.83 |
Other Current Liabilities | 387.19 | 299.45 | 263.74 | 265.42 | 214.24 |
Total Current Liabilities | 1,740 | 1,646 | 1,708 | 1,582 | 1,274 |
Long-Term Debt | 1,102 | 1,052 | 1,002 | 950.5 | 898.24 |
Long-Term Leases | 11.57 | 13.76 | 17.62 | 24.2 | 22.15 |
Long-Term Unearned Revenue | 1.54 | 1.35 | 1.74 | 2.3 | 2.29 |
Long-Term Deferred Tax Liabilities | 38.73 | 39.07 | 39.06 | 70.83 | 73.47 |
Other Long-Term Liabilities | 34.56 | 71.15 | 99.64 | 64.73 | 52.97 |
Total Liabilities | 2,928 | 2,823 | 2,868 | 2,695 | 2,323 |
Common Stock | 2,216 | 2,191 | 2,152 | 2,148 | 2,146 |
Additional Paid-In Capital | 1,081 | 1,063 | 871.65 | 635.69 | 572.22 |
Retained Earnings | 2,319 | 2,726 | 2,681 | 2,344 | 2,278 |
Treasury Stock | -120.64 | -120.64 | -120.64 | -120.64 | - |
Comprehensive Income & Other | 91.7 | 102.91 | 102.91 | 102.92 | 102.93 |
Total Common Equity | 5,586 | 5,962 | 5,687 | 5,110 | 5,100 |
Minority Interest | 9.19 | -27.95 | -5.81 | 16.84 | 73.46 |
Shareholders' Equity | 5,596 | 5,934 | 5,681 | 5,127 | 5,173 |
Total Liabilities & Equity | 8,523 | 8,756 | 8,549 | 7,822 | 7,496 |
Total Debt | 1,150 | 1,131 | 1,098 | 1,036 | 936.48 |
Net Cash (Debt) | 611.59 | 207.83 | 15.99 | 245.18 | 664.07 |
Net Cash Growth | 194.27% | 1199.84% | -93.48% | -63.08% | -18.20% |
Net Cash Per Share | 0.28 | 0.10 | 0.01 | 0.11 | 0.31 |
Filing Date Shares Outstanding | 2,201 | 2,198 | 2,145 | 2,133 | 2,146 |
Total Common Shares Outstanding | 2,201 | 2,177 | 2,138 | 2,133 | 2,146 |
Working Capital | 3,185 | 3,450 | 3,146 | 2,729 | 2,901 |
Book Value Per Share | 2.54 | 2.74 | 2.66 | 2.40 | 2.38 |
Tangible Book Value | 3,729 | 4,359 | 4,061 | 4,008 | 3,522 |
Tangible Book Value Per Share | 1.69 | 2.00 | 1.90 | 1.88 | 1.64 |
Buildings | 517.82 | 517.82 | 517.82 | 517.03 | 517.03 |
Machinery | 73.9 | 69.29 | 66.03 | 60.7 | 58.44 |
Construction In Progress | - | - | - | - | 1.29 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.